Search - tctmd.com

Displaying 641 - 660 of 8552

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1203: First Report of Intravenous Thrombolysis for the Treatment of Severe Aortic Insufficiency Following Transcatheter Aortic Valve Replacement

Presenter: Dhiran Verghese

October 30, 2024

Presentation TCT 2024

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

Presenter: Diego Bianchi

October 30, 2024

Presentation TCT 2024

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

Presenter: Julien Ternacle

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

My Personal Guide to Prevention and Management of Aortic Intra- and Perivalular Leaks?

Presenter: Ignacio Amat-Santos

October 30, 2024

Presentation TCT 2024

Lessons Learned From the SMART Trial

Presenter: Howard Herrmann

October 30, 2024

Presentation TCT 2024

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Presenter: Mahesh Madhavan

October 30, 2024

Presentation TCT 2024

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

Presenter: Philippe Pibarot

October 30, 2024

Presentation TCT 2024

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

Presenter: Santiago Garcia

October 30, 2024

Presentation TCT 2024

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

Presenter: Marco Ancona

October 30, 2024

Presentation TCT 2024

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

Presenter: G. Michael Deeb

October 30, 2024

Presentation TCT 2024

TCT 917: Transcatheter Aortic Valve Implantation With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The International Multicenter NAVULTRA Registry

Presenter: Stefano Cannata

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

Presenter: Vincent Lipari

October 30, 2024

Presentation TCT 2024

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

Presenter: Mohammad Reza Movahed

October 30, 2024

Presentation TCT 2024

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

Presenter: Constantijn Venema

October 30, 2024

Presentation TCT 2024

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

Presenter: Rishi Sukhija

October 30, 2024

Presentation TCT 2024

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

Presenter: Rupak Banerjee

October 30, 2024

Presentation TCT 2024

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Presenter: Zaid Abdulelah

October 30, 2024

Advertisement

TCT 1203: First Report of Intravenous Thrombolysis for the Treatment of Severe Aortic Insufficiency Following Transcatheter Aortic Valve Replacement

TCT 1190: Hostile Aorta: Valve, Grafts, Stents and Plug for Intervention

Prosthesis-Patient Mismatch: Definitions, Incidence, and Clinical Relevance in SAVR and TAVR Patients

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

My Personal Guide to Prevention and Management of Aortic Intra- and Perivalular Leaks?

Lessons Learned From the SMART Trial

Late Clinical Outcomes in Small Annulus Patients in the PARTNER Trials

Fifty Shades of Gray: The “Correct” Way to Diagnose Bioprosthetic Valve Durability

TCT 920: Early US Commercial Experience With an Intra-Annular, Self-Expandable Valve in High-Risk Patients: 30-Day Results From the Navitor™ Post-Approval Study

TCT 919: EasyCross Self-Centering Catheter to Facilitate Aortic Valve Crossing During TAVR: A First in Human Feasibility Trial

TCT 918: Association of TVT Site Risk Adjusted Stroke Rates and Joint Commission Stroke Certification Designation Level

TCT 917: Transcatheter Aortic Valve Implantation With Intra-Annular Self-Expanding or Balloon-Expandable Valves: The International Multicenter NAVULTRA Registry

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 650: Independent Predictors of 2-Year Mortality in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement

TCT 649: Mortality Is Lowest in Overweight Followed by Obese and Morbid Obese Patients and Is Highest in Cachexia Compared to Normal Weight in Patients With a Diagnosis of Aortic Stenosis

TCT 648: HFpEF Phenotype Is Associated With Early Symptom-Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement

TCT 647: A Novel Functional Index - Aortic Valve Coefficient (AVC) - For Assessing Low Flow-Low Gradient Aortic Valve Stenosis: A Prospective Study in Patients Undergoing TAVR

TCT 646: The Aortic Valve Coefficient (AVC) Cut-off Values for Improved Assessment of Aortic Stenosis Severity: A Prospective Study

TCT 645: Calcified Aortic Valve Disease-related Mortality Trends in the United States Over the Past 3 Decades

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content